Skip to main content
. Author manuscript; available in PMC: 2020 Feb 11.
Published in final edited form as: J Neurosci Res. 2018 Oct 13;97(2):137–148. doi: 10.1002/jnr.24335

Fig. 2.

Fig. 2

Expression of angiogenic factors in NCC model shown by inmunohistochemistry. Panel A, VEGF expression, Control region (Cp, [n=7]), parenchymal cyst (P, [n=11]), corticomeningeal cyst (Cm, [n=8]), control region of the ventricle (Cv, [n=5]), ventricular cyst (V, [n=8]). Panel B, FGF2 expression. Control region (Cp, [n=9]), parenchymal cyst (P, [n=10]), corticomeningeal cyst (Cm, [n=8]), control region of the ventricle (Cv, [n=5]), ventricular cyst (V, [n=8]). Control brains (i, ii) and infected brains (iii, iv). i, iii, scale bar 200um. ii, iv, scale bar 50um. v, comparison of the immunoreactive area by cyst location. Mann-Whitney U, P<0.05 (*), P<0.001 (**), P<0.0001 (***)